Continuing Education Activities

Evolving Role of Bispecific Antibodies as Cancer Therapy

Recorded from a livestreaming series on bispecific antibodies, this enduring material offers learners the opportunity to participate in tele-mentoring with a virtual team of expert faculty using the Project ECHO® Model.

Session 1: Overview   Session 2: Multiple Myeloma   Session 3: Diffuse Large B-Cell Lymphoma   Session 4: Follicular Lymphoma   Session 5: Guideline Development in the Community

Credits Available: This activity offers up to 5.0 hours of CME/CNE/CPE credit.
Enroll Today

Optimizing Advanced NSCLC Biomarker Testing, Treatment, and Management

This enduring material was recorded from an interactive, virtual (live) summit to enhance coordination of patient care and gain deeper scientific knowledge, skills, and competence in biomarker testing practices, treatment selection, and management of adverse events in patients with advanced NSCLC.

• Session 1:  Learn what factors influence testing selection for patients with advanced NSCLC.
• Session 2:  Gain clarity on biomarker testing methodology and recommendations.
• Session 3:  Hear insights on advanced NSCLC treatment opportunities and optimizing patient care.

Credits Available: This activity offers up to 4.5 hours of CME/CMLE credit.
Enroll Today

Emerging Therapies for the Management of Castration-Sensitive Prostate Cancer

Included in this course are data from the PEACE-1 phase 3 trial exploring triple therapy, ongoing trials in metastatic castration-sensitive prostate cancer, and quality of life studies on systemic therapies.

This activity provides guidance on the optimal management of mCSPC to oncologists, urologists, oncology advanced practitioners and other members of the multidisciplinary cancer care team. The program addresses some of the challenges in optimal sequencing of care in mCSPC and provides an opportunity to discuss with leading oncology experts and colleagues how new research clinical updates can be translated into new patient care strategies.

Speakers:

• Archana Ajmera, MSN, ANP-BC-AOCNP, Advanced Practice Provider Supervisor, Division of Hematology/Oncology, UCSD Moores Cancer Center
• Pedro C. Barata, MD, MSC, Assistant Professor, Deming Department of Medicine Division of Hematology/Oncology, Genitourinary Cancers Tulane University, Tulane University
• Erik Castle, MD, FACS, Professor of Urology, Tulane University
• Lisa M. Holle, PHARMD, BCOP, FHOPA, FISOPP, Clinical Professor of Pharmacy Practice, Department of Pharmacy Practice, UConn School of Medicine

View Course